Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88293599 | 8829359 | 9 | F | 20120621 | 20160816 | 20121008 | 20160818 | EXP | CA-ROCHE-1141436 | ROCHE | 64.20 | YR | F | Y | 68.10000 | KG | 20160818 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88293599 | 8829359 | 1 | PS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | LAST DOSE ON 18/JUN/2014. | 103705 | 1000 | MG | SOLUTION FOR INFUSION | |||||||
| 88293599 | 8829359 | 2 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 103705 | 1000 | MG | SOLUTION FOR INFUSION | ||||||||
| 88293599 | 8829359 | 3 | SS | DIPHENHYDRAMINE HCL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | 0 | 50 | MG | |||||||||
| 88293599 | 8829359 | 4 | SS | DIPHENHYDRAMINE HCL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | 0 | 25 | MG | |||||||||
| 88293599 | 8829359 | 5 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | 0 | ||||||||||||
| 88293599 | 8829359 | 6 | C | FLAXSEED | FLAX SEED | 1 | 0 | ||||||||||||
| 88293599 | 8829359 | 7 | C | DOCUSATE | DOCUSATE | 1 | Unknown | 0 | |||||||||||
| 88293599 | 8829359 | 8 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 88293599 | 8829359 | 9 | C | FERROUS FUMARATE | FERROUS FUMARATE | 1 | 0 | ||||||||||||
| 88293599 | 8829359 | 10 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 0 | 1000 | MG | |||||||||
| 88293599 | 8829359 | 11 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | 0 | 100 | MG | |||||||||
| 88293599 | 8829359 | 12 | C | AZATHIOPRINE. | AZATHIOPRINE | 1 | 0 | ||||||||||||
| 88293599 | 8829359 | 13 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 0 | 2 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 88293599 | 8829359 | 1 | Rheumatoid arthritis |
| 88293599 | 8829359 | 3 | Product used for unknown indication |
| 88293599 | 8829359 | 10 | Premedication |
| 88293599 | 8829359 | 13 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 88293599 | 8829359 | HO |
| 88293599 | 8829359 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 88293599 | 8829359 | Ankle fracture | |
| 88293599 | 8829359 | Arthralgia | |
| 88293599 | 8829359 | Diarrhoea | |
| 88293599 | 8829359 | Fall | |
| 88293599 | 8829359 | Fatigue | |
| 88293599 | 8829359 | Haemoptysis | |
| 88293599 | 8829359 | Hyperkeratosis | |
| 88293599 | 8829359 | Knee operation | |
| 88293599 | 8829359 | Somnolence | |
| 88293599 | 8829359 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 88293599 | 8829359 | 1 | 20110101 | 0 | ||
| 88293599 | 8829359 | 2 | 20110106 | 0 | ||
| 88293599 | 8829359 | 3 | 20110106 | 20140618 | 0 | |
| 88293599 | 8829359 | 4 | 20141223 | 0 | ||
| 88293599 | 8829359 | 7 | 201206 | 0 | ||
| 88293599 | 8829359 | 10 | 20110106 | 0 | ||
| 88293599 | 8829359 | 11 | 20110106 | 0 | ||
| 88293599 | 8829359 | 13 | 20100606 | 0 |